Antimicrobial Peptides Human β-Defensins Stimulate Epidermal Keratinocyte Migration, Proliferation and Production of Proinflammatory Cytokines and Chemokines

Journal of Investigative Dermatology - Tập 127 Số 3 - Trang 594-604 - 2007
François Niyonsaba1, Hiroko Ushio1, Nobuhiro Nakano1, William Ng1,2, Koji Sayama3, Koji Hashimoto3, Isao Nagaoka4, Ko Okumura5, Hideoki Ogawa1
1Atopy (Allergy) Research Center, Juntendo University School of Medicine, Tokyo, Japan
2Department of Dermatology, Juntendo University School of Medicine, Tokyo, Japan
3Department of Dermatology, Ehime University School of Medicine, Ehime, Japan
4Department of Host Defense and Biochemical Research, Juntendo University School of Medicine, Tokyo, Japan
5Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Aarbiou, 2002, Human neutrophil defensins induce lung epithelial cell proliferation in vitro, J Leukoc Biol, 72, 167, 10.1189/jlb.72.1.167

Aarbiou, 2004, Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro, Am J Respir Cell Mol Biol, 30, 193, 10.1165/rcmb.2002-0267OC

Ali, 2001, Expression of the peptide antibiotics human β-defensin-1 and human β-defensin-2 in normal human skin, J Invest Dermatol, 117, 106, 10.1046/j.0022-202x.2001.01401.x

Andl, 2004, EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes, Am J Physiol Gastrointest Liver Physiol, 287, G1227, 10.1152/ajpgi.00253.2004

Befus, 1999, Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action, J Immunol, 163, 947, 10.4049/jimmunol.163.2.947

Cha, 1996, Enhanced modulation of keratinocyte motility by transforming growth factor-α (TGF-α) relative to epidermal growth factor (EGF), J Invest Dermatol, 106, 590, 10.1111/1523-1747.ep12345083

Chaly, 2000, Neutrophil α-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells, Eur Cytokine Netw, 11, 257

Chen, 2005, Synergistic effect of antibacterial agents human β-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli, J Dermatol Sci, 40, 123, 10.1016/j.jdermsci.2005.03.014

Chertov, 1996, Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils, J Biol Chem, 271, 2935, 10.1074/jbc.271.6.2935

Clapham, 1995, Calcium signaling, Cell, 80, 259, 10.1016/0092-8674(95)90408-5

Dorschner, 2001, Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus, J Invest Dermatol, 117, 91, 10.1046/j.1523-1747.2001.01340.x

Frank, 1999, Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling, Nat Med, 5, 444, 10.1038/7445

Frohm, 1999, The human cationic antimicrobial protein (hCAP-18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6, Infect Immun, 67, 2561, 10.1128/IAI.67.5.2561-2566.1999

Fulton, 1997, Expression of natural peptide antibiotics in human skin, Lancet, 350, 1750, 10.1016/S0140-6736(05)63574-X

García, 2001, Identification of a novel, multifunctional β-defensin (human β-defensin-3) with specific antimicrobial activity: Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction, Cell Tissue Res, 306, 257, 10.1007/s004410100433

García, 2001, Human β-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity, FASEB J, 15, 1819, 10.1096/fj.00-0865fje

Harder, 1997, A peptide antibiotic from human skin, Nature, 387, 861, 10.1038/43088

Harder, 2001, Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic, J Biol Chem, 276, 5707, 10.1074/jbc.M008557200

Harder, 2004, Differential gene induction of human β-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid, J Invest Dermatol, 123, 522, 10.1111/j.0022-202X.2004.23234.x

Heilborn, 2003, The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium, J Invest Dermatol, 120, 379, 10.1046/j.1523-1747.2003.12069.x

Hou, 2004, In vivo activity of a phospholipase C inhibitor, 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl) amino) hexyl)-1H-pyrrole-2,5-dione (U73122), in acute and chronic inflammatory reactions, J Pharmacol Exp Ther, 309, 697, 10.1124/jpet.103.060574

Huh, 2002, Dynamic alteration of human β-defensin 2 localization from cytoplasm to intercellular space in psoriatic skin, J Mol Med, 80, 678, 10.1007/s00109-002-0373-z

Jia, 2001, Discovery of new human β-defensins using a genomics-based approach, Gene, 263, 211, 10.1016/S0378-1119(00)00569-2

Kehrl, 1998, Heterotrimeric G protein signaling: roles in immune function and fine-tuning by RGS proteins, Immunity, 8, 1, 10.1016/S1074-7613(00)80453-7

Kijima, 2002, STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo, Cell Growth Differ, 13, 355

Knall, 1998, G-protein regulatory pathways: rocketing into the twenty-first century, J Cell Biochem Suppl, 30/31, 137, 10.1002/(SICI)1097-4644(1998)72:30/31+<137::AID-JCB18>3.0.CO;2-L

Koczulla, 2003, An angiogenic role for the human peptide antibiotic LL-37/hCAP-18, J Clin Invest, 111, 1665, 10.1172/JCI17545

Lehrer, 1999, Antimicrobial peptides in mammalian and insect host defense, Curr Opin Immunol, 11, 23, 10.1016/S0952-7915(99)80005-3

Li, 2004, Signals that initiate, augment, and provide directionality for human keratinocyte motility, J Invest Dermatol, 123, 622, 10.1111/j.0022-202X.2004.23416.x

Liu, 2002, Human β-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentation, J Invest Dermatol, 118, 275, 10.1046/j.0022-202x.2001.01651.x

Niyonsaba, 2001, Evaluation of the effects of peptide antibiotics human β-defensins-1/-2 and LL-37 on histamine release and prostaglandin D2 production from mast cells, Eur J Immunol, 31, 1066, 10.1002/1521-4141(200104)31:4<1066::AID-IMMU1066>3.0.CO;2-#

Niyonsaba, 2002, Epithelial cell-derived human β-defensin-2 acts as chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway, Int Immunol, 14, 421, 10.1093/intimm/14.4.421

Niyonsaba, 2002, A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis, Immunology, 106, 20, 10.1046/j.1365-2567.2002.01398.x

Niyonsaba, 2004, Human β-defensin-2 functions as a chemotactic agent for tumour necrosis factor-α-treated human neutrophils, Immunology, 111, 273, 10.1111/j.0019-2805.2004.01816.x

Niyonsaba, 2005, The human β-defensins (hBD-1, -2, -3, -4) and cathelicidin LL-37 induce interleukin-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes, J Immunol, 175, 1776, 10.4049/jimmunol.175.3.1776

Ong, 2002, Endogenous antimicrobial peptides and skin infections in atopic dermatitis, New Engl J Med, 347, 1151, 10.1056/NEJMoa021481

Oppenheim, 2003, Roles of antimicrobial peptides such as defensins in innate and adaptive immunity, Ann Rheum Dis, 62, 17, 10.1136/ard.62.suppl_2.ii17

Oren, 2003, In human epidermis, β-defensin 2 is packaged in lamellar bodies, Exp Mol Pathol, 74, 180, 10.1016/S0014-4800(02)00023-0

Sano, 1999, Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis, EMBO J, 18, 4657, 10.1093/emboj/18.17.4657

Shaykhiev, 2005, The human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure, Am J Physiol Lung Cell Mol Physiol, 289, L842, 10.1152/ajplung.00286.2004

Sørensen, 1997, The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils, Blood, 90, 2796, 10.1182/blood.V90.7.2796

Sørensen, 2005, Differential regulation of β-defensin expression in human skin by microbial stimuli, J Immunol, 174, 4870, 10.4049/jimmunol.174.8.4870

Tokumaru, 2005, Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37, J Immunol, 175, 4662, 10.4049/jimmunol.175.7.4662

Yang, 1999, defensins: linking innate and adaptive immunity through dendritic and T cell CCR6, Science, 286, 525, 10.1126/science.286.5439.525

Yang, 2000, LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells, J Exp Med, 192, 1069, 10.1084/jem.192.7.1069

Zahm, 2000, Mitogenic effect of recombinant HGF on airway epithelial cells during the in vitro wound repair of the respiratory epithelium, J Cell Physiol, 185, 447, 10.1002/1097-4652(200012)185:3<447::AID-JCP16>3.0.CO;2-D

Zanetti, 1995, Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain, FEBS Lett, 374, 1, 10.1016/0014-5793(95)01050-O

Zhang, 2001, Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion, Am J Physiol Lung Cell Mol Physiol, 280, L947, 10.1152/ajplung.2001.280.5.L947